Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-007072
Filing Date
2025-05-09
Accepted
2025-05-09 08:10:16
Documents
108
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vreof-20250331x10q.htm   iXBRL 10-Q 1472471
2 EX-31.1 vreof-20250331xex31d1.htm EX-31.1 7858
3 EX-31.2 vreof-20250331xex31d2.htm EX-31.2 8547
4 EX-32.1 vreof-20250331xex32d1.htm EX-32.1 9934
  Complete submission text file 0001558370-25-007072.txt   8451774

Data Files

Seq Description Document Type Size
5 EX-101.SCH vreof-20250331.xsd EX-101.SCH 81836
6 EX-101.CAL vreof-20250331_cal.xml EX-101.CAL 78971
7 EX-101.DEF vreof-20250331_def.xml EX-101.DEF 271839
8 EX-101.LAB vreof-20250331_lab.xml EX-101.LAB 617193
9 EX-101.PRE vreof-20250331_pre.xml EX-101.PRE 480906
111 EXTRACTED XBRL INSTANCE DOCUMENT vreof-20250331x10q_htm.xml XML 1429704
Mailing Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402 604-617-5421
Vireo Growth Inc. (Filer) CIK: 0001771706 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56225 | Film No.: 25928463
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)